Skip to Main Content

Try STAT+ TODAY

Valeant Pharmaceuticals

Most Read

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: FTC is ‘aware’ of concerns over possible Mylan antitrust violations

Pharmalot Ed Silverman

Feds charge former Valeant and Philidor execs with fraud

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Valeant may change its name to create a new image

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Glaxo CEO looks for drug prices to fall no matter who is president

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Valeant sued by Sprout investors over female libido pill

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Valeant looks to sell Salix to lessen debt load

Pharmalot Ed Silverman

Former Valeant CEO and CFO are being investigated by the feds

Pharmalot Ed Silverman

Congressman calls for probe into Valeant’s pricing of lead poisoning drug

All Coverage

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Valeant avoids double-digit price hikes with 9.9 percent increases

advertisement

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Pfizer pays $14 billion for Medivation and its prostate cancer drug

Pharmalot Ed Silverman

Valeant gets poor grades for its Addyi female libido pill

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Valeant under criminal investigation for defrauding insurers

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Valeant reorganizes and maintains earnings forecast

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Valeant overhauls part of its management team

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Valeant losing a crucial revenue tool

The Pharmalot View Ed Silverman

Pharma trade group says price gougers are outliers, but then accepts two more

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: FDA overlooks troubles at Chinese supplier to avoid shortages

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Novartis stops making TB drugs in Pakistan, prompting fear of a health crisis

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: FDA reviewers say Valeant drug carries suicide risks

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Medivation to start takeover talks with Sanofi and others

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: India inspects 200 drug makers for poor-quality meds